Shannon Kauffman, PA
Payments from drug & device makers
Across 36 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$82
- AstraZeneca$74
- AbbVie$57
- Amarin Pharma, Inc.$49
- Boehringer Ingelheim$48
- Xeris Pharmaceuticals, Inc.$48
- plus $266 from 11 others
What the payments were for
- Food & beverage$625100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $82 |
| AstraZeneca | 4 | $74 |
| AbbVie | 4 | $57 |
| Amarin Pharma, Inc. | 3 | $49 |
| Boehringer Ingelheim | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| Viatris Specialty LLC | 2 | $46 |
| Lilly USA, LLC | 3 | $43 |
| Acadia Pharmaceuticals Inc | 1 | $34 |
| Johnson & Johnson | 2 | $29 |
| Exact Sciences | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Pfizer | 1 | $15 |
| GSK | 1 | $15 |
| Merck | 1 | $14 |
| Amgen | 1 | $12 |
How this compares
$625 in reported general payments places this provider in the 45th percentile of 233 medical providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $556 |
| Cephalexin | 12 | $445 |
| Levothyroxine Sodium | 34 | $404 |
| Atorvastatin Calcium | 38 | $328 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $296 |
| Losartan Potassium | 22 | $264 |
| Pantoprazole Sodium | 16 | $254 |
| Fluticasone Propionate | 26 | $229 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $187 |
| Amlodipine Besylate | 33 | $181 |
| Montelukast Sodium | 11 | $158 |
| Sertraline Hcl | 11 | $155 |
| Metoprolol Succinate | 18 | $149 |
| Simvastatin | 19 | $145 |
| Fluconazole | 40 | $142 |
Paid to pharmacies, not to this prescriber.
Other medical in Davis
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
- Mohammad YousafCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.